The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Joint Symposium

[JS16★☆]The 10th clinical chemistry opens up novel pharmacotherapeutic strategies
—Creating new value through innovation based on collaboration between pharmacy, clinical chemistry, and "+α"—

Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 05 (F401, Bldg. 4, Area 2 [4F])
Organizer: Hirofumi Jono (Dept. Pharm. Sci., Kumamoto Univ. Hosp.), Masamitsu Maekawa (Dept. Pharm. Sci., Tohoku Univ. Hosp.)
Co-sponsored by:
The Pharmaceutical Society of Japan,
Japan Society of Clinical Chemistry
Clinical chemistry is a field of study that provides medical care with clinical chemistry testing based on analytical techniques, while aiming to elucidate disease causes and pathologies and contribute to treatment and prevention. In pharmacy as well, the latest knowledge and concepts of clinical chemistry, grounded in clinical testing, are becoming indispensable for implementing appropriate drug therapy in clinical settings. This includes therapeutic drug monitoring utilizing drug blood concentrations and clinical test values, personalized medicine based on genomic information, and biomarker development through omics analysis leveraging mass spectrometry technology.
This symposium, co-hosted with the Japan Society of Clinical Chemistry to highlight clinical chemistry's contributions to healthcare, will present the latest research findings in diverse molecular analysis technologies from clinical chemistry, pharmacy, and other academic fields. Titled "Creating New Value through Innovation: Pharmacy × Clinical Chemistry × [+α]," we will present the latest insights into developing biomarkers useful for early diagnosis, stratification, and detecting side effects. We aim to discuss the potential for the convergent development of clinical chemistry and pharmacy, which is indispensable for effective diagnosis and drug therapy practice.
1:10 PM - 1:15 PM JST(4:10 AM - 4:15 AM UTC)

Opening Remarks
Hirofumi Jono (Dept. Pharm. Sci., Kumamoto Univ. Hosp.)

1:15 PM - 1:37 PM JST(4:15 AM - 4:37 AM UTC)

[JS16-1]Advances in mass spectrometry imaging technology for understanding spatial molecular information: potential applications in clinical chemistry

○Yoichi Otsuka1 (1. The Univ. Osaka)
1:37 PM - 1:59 PM JST(4:37 AM - 4:59 AM UTC)

[JS16-2]Accurate diagnosis of amyloidosis: a growing imperative in the era of novel therapeutics

○Masayoshi Tasaki1, Mitsuharu Ueda1 (1. Kumamoto Univ.)
1:59 PM - 2:21 PM JST(4:59 AM - 5:21 AM UTC)

[JS16-3]Mechanistic analysis of ABCB4 using the enzymatic fluorometric assay for phospholipid

○Yoshito Ikeda1 (1. Dpt. Pharm. Shiga Univ. Med. Sci. Hosp.)
2:21 PM - 2:43 PM JST(5:21 AM - 5:43 AM UTC)

[JS16-4]Pharmacokinetic Prediction for the Optimization of Perinatal and Neonatal Pharmacotherapy

○Kazuhiro Yamamoto1 (1. Department of Integrated Clinical and Basic Pharmaceutical Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)
2:43 PM - 3:05 PM JST(5:43 AM - 6:05 AM UTC)

[JS16-5]Clinical Chemistry Research Toward the Creation of Precision Diagnostics and Personalized Drug Therapy Based on Comprehensive Molecular analysis by LC/MS/MS

○Masamitsu Maekawa1,2,3,4,5, Nariyasu Mano1,2,3 (1. Dept. Pharm. Sci., Tohoku Univ. Hosp., 2. Tohoku Univ. Grad. Med. Sch., 3. Grad. Sch. Pharm. Sci., Tohoku Univ., 4. INGEM, Tohoku Univ., 5. The Univ. Osaka)
3:05 PM - 3:10 PM JST(6:05 AM - 6:10 AM UTC)

Closing Remarks
Masamitsu Maekawa1,2,3,4,5（1 Dept. Pharm. Sci., Tohoku Univ. Hosp.,2 Tohoku Univ. Grad. Med. Sch.,3 Grad. Sch. Pharm. Sci., Tohoku Univ., 4 INGEM, Tohoku Univ., 5 The Univ. Osaka）

Back to Category List